The latest news from Sidec AB.
New movie presenting Protein Tomography™.
4:17 min - Requires Flash Player
View movie (7,9 MB)
Request movie on CD here
Head of Business Development
Jack Elands
Phone: +44 7947 870 482
jack.elands@sidec.com
Sign up for e-mail notifications of important Sidec news.
(May 06, 2008 04:13 PM)Sidec AB, announces today that it has moved to a new facility in Kista, Sweden. The new 8600 square-foot facility will enable Sidec to continue its market expansion and to recruit further new staff. In the past 12 month Sidec has grown from 20 to 40 employees.
Sidec is the leading provider of three-dimensional (3D) images of individual proteins visualizing and interpreting drug-target interaction in situ and in vitro for a rapid localization of antibody binding epitopes and validation of molecular mode of action.
With Sidec’s proprietary technology; Protein Tomography™, it is possible to study monoclonal antibody/receptor interactions and reveal the molecular impact of the drug molecule on its target.
“This unique and new technology enables you to actually see the individual molecules in situ to define the epitopes and protect your intellectual property with visual evidence, as well as prioritizing the most promising projects.” Says Hans Johansson CEO Sidec . “This new facility combined with a rapidly growing interest from our customers and € 7 million provided last year by our owners Investor Growth Capital, EarlyBird Ventures and Industrifonden will enable Sidec to expand to its full potential".